HLA-F
関連文献

“Structure--function relationships in HIV-1 Nef”. EMBO Reports 2 (7):  580–585. (July 2001). doi:10.1093/embo-reports/kve141. PMC 1083955. PMID 11463741. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1083955/.
“HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication”. Journal of Biosciences 28 (3):  323–335. (April 2003). doi:10.1007/BF02970151. PMID 12734410.
“[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]”. Médecine/Sciences 19 (1):  100–106. (January 2003). doi:10.1051/medsci/2003191100. PMID 12836198.
“Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm”. Current Protein & Peptide Science 5 (1):  1–8. (February 2004). doi:10.2174/1389203043486955. PMID 14965316.
“HIV/SIV escape from immune surveillance: focus on Nef”. Current HIV Research 2 (2):  141–151. (April 2004). doi:10.2174/1570162043484924. PMID 15078178.
“Nef: "necessary and enforcing factor" in HIV infection”. Current HIV Research 3 (1):  87–94. (January 2005). doi:10.2174/1570162052773013. PMID 15638726.
“HIV accessory proteins and surviving the host cell”. Current HIV/AIDS Reports 1 (1):  47–53. (April 2004). doi:10.1007/s11904-004-0007-x. PMID 16091223.
“Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules”. The Journal of Experimental Medicine 175 (6):  1417–1422. (June 1992). doi:10.1084/jem.175.6.1417. PMC 2119225. PMID 1316930. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119225/.
“The human class I MHC gene HLA-F is expressed in lymphocytes”. International Immunology 2 (6):  531–537. (1991). doi:10.1093/intimm/2.6.531. PMID 1707659.
“A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160”. Science 246 (4926):  118–121. (October 1989). Bibcode: 1989Sci...246..118T. doi:10.1126/science.2789433. PMID 2789433.
“Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120”. European Journal of Immunology 25 (5):  1306–1311. (May 1995). doi:10.1002/eji.1830250526. PMID 7539755.
“HIV Tat represses transcription through Sp1-like elements in the basal promoter”. Immunity 3 (1):  127–138. (July 1995). doi:10.1016/1074-7613(95)90165-5. PMID 7621073.
“HIV-1 gp41 enhances major histocompatibility complex class I and ICAM-1 expression on H9 and U937 cells”. International Archives of Allergy and Immunology 104 (3):  227–231. (July 1994). doi:10.1159/000236670. PMID 7913356.
“HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41”. Molecular Immunology 31 (13):  977–982. (September 1994). doi:10.1016/0161-5890(94)90092-2. PMID 8084338.
“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene 138 (1–2):  171–174. (January 1994). doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
“Repression of MHC class I gene promoter activity by two-exon Tat of HIV”. Science 260 (5112):  1320–1322. (May 1993). Bibcode: 1993Sci...260.1320H. doi:10.1126/science.8493575. PMID 8493575. https://zenodo.org/record/1231261.
“Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F”. Human Molecular Genetics 2 (5):  571–576. (May 1993). doi:10.1093/hmg/2.5.571. PMID 8518796.
“Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein”. Nature Medicine 2 (3):  338–342. (March 1996). doi:10.1038/nm0396-338. PMID 8612235.
“Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes”. International Immunology 8 (5):  641–649. (May 1996). doi:10.1093/intimm/8.5.641. PMID 8671651.